<DOC>
	<DOCNO>NCT01759355</DOCNO>
	<brief_summary>This two arm , single center feasibility study 20 patient non-metastatic cervical cancer manage surgery and/or chemoradiation therapy UNC Hospitals . Subjects undergo PET/MRI scan , ( chemoradiation group ) , treatment .</brief_summary>
	<brief_title>Hybrid PET/MR Therapy Cervical Cancer</brief_title>
	<detailed_description>The primary purpose study evaluate feasibility obtain complete interpretable hybrid PET/MR image patient diagnosed cervical cancer .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Adenosquamous</mesh_term>
	<criteria>≥ 18 year age Biopsyproven , previously untreated squamous cell carcinoma , adenosquamous carcinoma , adenocarcinoma uterine cervix Clinically visible lesion least FIGO stage Ib AJCC 7th edition T1b Scheduled undergo standard care PET/CT baseline assessment disease Anticipated eligible curative intent therapy ( surgery chemoradiation therapy ) determine patient 's primary oncologist If female childbearing potential , negative serum urine pregnancy test ≤ 7 dat prior first PET/MRI Informed consent review signed History sever reaction contrastenhanced CT scan Inability tolerate MRI ( e.g. , inability lie flat &gt; 1 hour ) Presence pacemaker , intracranial aneurysm clip , bladder stimulator , cochlear implant metal near eye Poorly control diabetes mellitus Creatinine &gt; 1.4 mg/dL GFR &lt; 30 mL/min Body Mass Index ( BMI ) &gt; 35 Active vaginal bleeding require pack emergent radiation therapy Pregnant lactate female History prior malignancy within past 5 year , unless disease free ≥ 3 year Substance abuse , medical , psychological , social condition may interfere study participation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>